| St. Louis, MO (October 21, 2006) – More than 6,000 professionals will gather at the Miami Beach Convention Center October 21st to experience the AABB Annual Meeting and TXPO 2006. The meeting, which primarily attracts transfusion and cellular therapy experts, will offer educational experiences with help from bioMérieux, an industrial microbiology and diagnostics company. The company can be spotted by their oversized exhibit booth (#325) where they will display the BacT/ALERT® 3D, an automated microbial bacterial detection system designed to provide laboratories with platelet bacterial quality control testing capabilities.
The automated system provides bacterial quality control testing of leukocyte reduced apheresis platelet (LRAP) units and both leukocyte reduced single units and for pools of up to six (6) units of leukocyte reduced whole blood platelet concentrates. The BacT/ALERT also provides lab professionals with user-friendly, labor-reducing features such as built-in test cell quality control, immediate bottle recognition and rapid response time for microbial detection.
Used in conjunction with the BacT/ALERT 3D are the BacT/ALERT Plastic Blood Culture Bottles. Currently the only company to develop and manufacture plastic bottles in the industry, bioMérieux has enhanced lab safety by minimizing or reducing the chance of sharp exposures and hazardous blood borne pathogens. With only half the weight of glass bottles, the BacT/ALERT plastic bottles offer the same features as glass but with improved safety and decreased waste disposal costs.
“We’re proud to offer highly innovative products to one of our core industries,” said Eric Bouvier, bioMérieux’s North American President and CEO. “We are constantly striving to deliver the most cutting-edge products and technologies to our valued customers in the blood banking industry.”
bioMérieux will host the 2nd Annual Customer Symposium, entitled, “Innovation@Work For Platelet Bacterial Detection Testing” on Monday, October 23rd in Miami Beach. Customers are invited to attend the educational and knowledge based forum at the Ritz-Carlton in the heart of South Beach. The symposium will feature three presenters, including Larry Dumont, MBA, Ph.D., assistant professor at the Dartmouth Medical School; Helen Pleasant, Manufacturing Process Specialist, Blood Systems, Inc.; and Olivier Pasquier, bioMérieux’s Global Product Manager of Molecular Biology. Customers are encouraged to participate in the symposium, and will also be given the opportunity to earn PACE credits on topics including platelet storage, the BacT/ALERT 3D testing optimization, and bioMérieux molecular solutions and innovations.
Visit bioMérieux in Miami Beach, Florida at the AABB Annual Meeting and TXPO 2006 at booth #325. The show will be at the Miami Beach Convention Center from October 21-24, 2006.
About bioMérieux
bioMérieux is a leading international diagnostics group that specializes in the field of in vitro diagnostics for clinical and industrial applications.bioMérieux designs, develops, manufactures and markets systems (i.e. reagents, instruments and software) used in:
Clinical applications: the diagnosis of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory illnesses, as well as pathologies such as certain cardiovascular diseases and certain cancers, based on the analysis of biological samples (such as blood, saliva or urine); and
Industrial applications: the microbiological analysis of food, environments (such as water and air), surfaces and pharmaceutical and cosmetic products, based on product or environmental samples.
In 2005, bioMérieux sales reached 994 million euros. The company is present in more than 130 countries through 35 subsidiaries and a large network of distributors, which positions the company well to benefit from the growth potential of the in vitro diagnostics market. Some important drivers that underpin this growth are aging populations and age-related illness, illnesses related to life-style and eating habits, emerging new pathogens, the development of antibiotic -resistant bacteria, the fight against bio-terrorism, and the recognition of the importance of the quality of food products. bioMérieux is listed on the Eurolist of Euronext, Paris (FR0010096479 – BIM).Other information can be found at www.biomerieux-usa.com.
|
